1 Recombinant Hormone Market Overview 1.1 Product Overview and Scope of Recombinant Hormone 1.2 Recombinant Hormone Segment by Type 1.2.1 Global Recombinant Hormone Market Value Comparison by Type (2023-2029) 1.2.2 Growth Hormone 1.2.3 Insulin 1.2.4 Follicle-stimulating Hormone 1.2.5 Others 1.3 Recombinant Hormone Segment by Application 1.3.1 Global Recombinant Hormone Market Value by Application: (2023-2029) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Recombinant Hormone Market Size Estimates and Forecasts 1.4.1 Global Recombinant Hormone Revenue 2018-2029 1.4.2 Global Recombinant Hormone Sales 2018-2029 1.4.3 Global Recombinant Hormone Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Recombinant Hormone Market Competition by Manufacturers 2.1 Global Recombinant Hormone Sales Market Share by Manufacturers (2018-2023) 2.2 Global Recombinant Hormone Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Recombinant Hormone Average Price by Manufacturers (2018-2023) 2.4 Global Recombinant Hormone Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Recombinant Hormone, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Recombinant Hormone, Product Type & Application 2.7 Recombinant Hormone Market Competitive Situation and Trends 2.7.1 Recombinant Hormone Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Recombinant Hormone Players Market Share by Revenue 2.7.3 Global Recombinant Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Hormone Retrospective Market Scenario by Region 3.1 Global Recombinant Hormone Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Recombinant Hormone Global Recombinant Hormone Sales by Region: 2018-2029 3.2.1 Global Recombinant Hormone Sales by Region: 2018-2023 3.2.2 Global Recombinant Hormone Sales by Region: 2024-2029 3.3 Global Recombinant Hormone Global Recombinant Hormone Revenue by Region: 2018-2029 3.3.1 Global Recombinant Hormone Revenue by Region: 2018-2023 3.3.2 Global Recombinant Hormone Revenue by Region: 2024-2029 3.4 North America Recombinant Hormone Market Facts & Figures by Country 3.4.1 North America Recombinant Hormone Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Recombinant Hormone Sales by Country (2018-2029) 3.4.3 North America Recombinant Hormone Revenue by Country (2018-2029) 3.4.4 United States 3.4.5 Canada 3.5 Europe Recombinant Hormone Market Facts & Figures by Country 3.5.1 Europe Recombinant Hormone Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Recombinant Hormone Sales by Country (2018-2029) 3.5.3 Europe Recombinant Hormone Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Recombinant Hormone Market Facts & Figures by Country 3.6.1 Asia Pacific Recombinant Hormone Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Recombinant Hormone Sales by Country (2018-2029) 3.6.3 Asia Pacific Recombinant Hormone Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 China Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.7 Latin America Recombinant Hormone Market Facts & Figures by Country 3.7.1 Latin America Recombinant Hormone Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Recombinant Hormone Sales by Country (2018-2029) 3.7.3 Latin America Recombinant Hormone Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Recombinant Hormone Market Facts & Figures by Country 3.8.1 Middle East and Africa Recombinant Hormone Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Recombinant Hormone Sales by Country (2018-2029) 3.8.3 Middle East and Africa Recombinant Hormone Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Recombinant Hormone Sales by Type (2018-2029) 4.1.1 Global Recombinant Hormone Sales by Type (2018-2023) 4.1.2 Global Recombinant Hormone Sales by Type (2024-2029) 4.1.3 Global Recombinant Hormone Sales Market Share by Type (2018-2029) 4.2 Global Recombinant Hormone Revenue by Type (2018-2029) 4.2.1 Global Recombinant Hormone Revenue by Type (2018-2023) 4.2.2 Global Recombinant Hormone Revenue by Type (2024-2029) 4.2.3 Global Recombinant Hormone Revenue Market Share by Type (2018-2029) 4.3 Global Recombinant Hormone Price by Type (2018-2029) 5 Segment by Application 5.1 Global Recombinant Hormone Sales by Application (2018-2029) 5.1.1 Global Recombinant Hormone Sales by Application (2018-2023) 5.1.2 Global Recombinant Hormone Sales by Application (2024-2029) 5.1.3 Global Recombinant Hormone Sales Market Share by Application (2018-2029) 5.2 Global Recombinant Hormone Revenue by Application (2018-2029) 5.2.1 Global Recombinant Hormone Revenue by Application (2018-2023) 5.2.2 Global Recombinant Hormone Revenue by Application (2024-2029) 5.2.3 Global Recombinant Hormone Revenue Market Share by Application (2018-2029) 5.3 Global Recombinant Hormone Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Eli Lilly and Company 6.1.1 Eli Lilly and Company Corporation Information 6.1.2 Eli Lilly and Company Description and Business Overview 6.1.3 Eli Lilly and Company Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Eli Lilly and Company Recombinant Hormone Product Portfolio 6.1.5 Eli Lilly and Company Recent Developments/Updates 6.2 Ferring Pharmaceuticals 6.2.1 Ferring Pharmaceuticals Corporation Information 6.2.2 Ferring Pharmaceuticals Description and Business Overview 6.2.3 Ferring Pharmaceuticals Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Ferring Pharmaceuticals Recombinant Hormone Product Portfolio 6.2.5 Ferring Pharmaceuticals Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Merck Recombinant Hormone Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Pfizer Recombinant Hormone Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Novo Nordisk 6.5.1 Novo Nordisk Corporation Information 6.5.2 Novo Nordisk Description and Business Overview 6.5.3 Novo Nordisk Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.5.4 Novo Nordisk Recombinant Hormone Product Portfolio 6.5.5 Novo Nordisk Recent Developments/Updates 6.6 Novartis AG 6.6.1 Novartis AG Corporation Information 6.6.2 Novartis AG Description and Business Overview 6.6.3 Novartis AG Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Novartis AG Recombinant Hormone Product Portfolio 6.6.5 Novartis AG Recent Developments/Updates 6.7 Ipsen 6.6.1 Ipsen Corporation Information 6.6.2 Ipsen Description and Business Overview 6.6.3 Ipsen Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Ipsen Recombinant Hormone Product Portfolio 6.7.5 Ipsen Recent Developments/Updates 6.8 LG Chem 6.8.1 LG Chem Corporation Information 6.8.2 LG Chem Description and Business Overview 6.8.3 LG Chem Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.8.4 LG Chem Recombinant Hormone Product Portfolio 6.8.5 LG Chem Recent Developments/Updates 6.9 Teva Pharmaceutical 6.9.1 Teva Pharmaceutical Corporation Information 6.9.2 Teva Pharmaceutical Description and Business Overview 6.9.3 Teva Pharmaceutical Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Teva Pharmaceutical Recombinant Hormone Product Portfolio 6.9.5 Teva Pharmaceutical Recent Developments/Updates 6.10 Scripps Laboratories 6.10.1 Scripps Laboratories Corporation Information 6.10.2 Scripps Laboratories Description and Business Overview 6.10.3 Scripps Laboratories Recombinant Hormone Sales, Revenue and Gross Margin (2018-2023) 6.10.4 Scripps Laboratories Recombinant Hormone Product Portfolio 6.10.5 Scripps Laboratories Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Recombinant Hormone Industry Chain Analysis 7.2 Recombinant Hormone Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Recombinant Hormone Production Mode & Process 7.4 Recombinant Hormone Sales and Marketing 7.4.1 Recombinant Hormone Sales Channels 7.4.2 Recombinant Hormone Distributors 7.5 Recombinant Hormone Customers 8 Recombinant Hormone Market Dynamics 8.1 Recombinant Hormone Industry Trends 8.2 Recombinant Hormone Market Drivers 8.3 Recombinant Hormone Market Challenges 8.4 Recombinant Hormone Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Recombinant Hormone Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Recombinant Hormone Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Recombinant Hormone Market Competitive Situation by Manufacturers in 2022 Table 4. Global Recombinant Hormone Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Recombinant Hormone Sales Market Share by Manufacturers (2018-2023) Table 6. Global Recombinant Hormone Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Recombinant Hormone Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Recombinant Hormone Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Recombinant Hormone, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Recombinant Hormone, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Recombinant Hormone, Product Type & Application Table 12. Global Key Manufacturers of Recombinant Hormone, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Recombinant Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hormone as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Recombinant Hormone Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Recombinant Hormone Sales by Region (2018-2023) & (K Units) Table 18. Global Recombinant Hormone Sales Market Share by Region (2018-2023) Table 19. Global Recombinant Hormone Sales by Region (2024-2029) & (K Units) Table 20. Global Recombinant Hormone Sales Market Share by Region (2024-2029) Table 21. Global Recombinant Hormone Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Recombinant Hormone Revenue Market Share by Region (2018-2023) Table 23. Global Recombinant Hormone Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Recombinant Hormone Revenue Market Share by Region (2024-2029) Table 25. North America Recombinant Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Recombinant Hormone Sales by Country (2018-2023) & (K Units) Table 27. North America Recombinant Hormone Sales by Country (2024-2029) & (K Units) Table 28. North America Recombinant Hormone Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Recombinant Hormone Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Recombinant Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Recombinant Hormone Sales by Country (2018-2023) & (K Units) Table 32. Europe Recombinant Hormone Sales by Country (2024-2029) & (K Units) Table 33. Europe Recombinant Hormone Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Recombinant Hormone Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Recombinant Hormone Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Recombinant Hormone Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Recombinant Hormone Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Recombinant Hormone Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Recombinant Hormone Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Recombinant Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Recombinant Hormone Sales by Country (2018-2023) & (K Units) Table 42. Latin America Recombinant Hormone Sales by Country (2024-2029) & (K Units) Table 43. Latin America Recombinant Hormone Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Recombinant Hormone Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Recombinant Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Recombinant Hormone Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Recombinant Hormone Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Recombinant Hormone Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Recombinant Hormone Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Recombinant Hormone Sales (K Units) by Type (2018-2023) Table 51. Global Recombinant Hormone Sales (K Units) by Type (2024-2029) Table 52. Global Recombinant Hormone Sales Market Share by Type (2018-2023) Table 53. Global Recombinant Hormone Sales Market Share by Type (2024-2029) Table 54. Global Recombinant Hormone Revenue (US$ Million) by Type (2018-2023) Table 55. Global Recombinant Hormone Revenue (US$ Million) by Type (2024-2029) Table 56. Global Recombinant Hormone Revenue Market Share by Type (2018-2023) Table 57. Global Recombinant Hormone Revenue Market Share by Type (2024-2029) Table 58. Global Recombinant Hormone Price (US$/Unit) by Type (2018-2023) Table 59. Global Recombinant Hormone Price (US$/Unit) by Type (2024-2029) Table 60. Global Recombinant Hormone Sales (K Units) by Application (2018-2023) Table 61. Global Recombinant Hormone Sales (K Units) by Application (2024-2029) Table 62. Global Recombinant Hormone Sales Market Share by Application (2018-2023) Table 63. Global Recombinant Hormone Sales Market Share by Application (2024-2029) Table 64. Global Recombinant Hormone Revenue (US$ Million) by Application (2018-2023) Table 65. Global Recombinant Hormone Revenue (US$ Million) by Application (2024-2029) Table 66. Global Recombinant Hormone Revenue Market Share by Application (2018-2023) Table 67. Global Recombinant Hormone Revenue Market Share by Application (2024-2029) Table 68. Global Recombinant Hormone Price (US$/Unit) by Application (2018-2023) Table 69. Global Recombinant Hormone Price (US$/Unit) by Application (2024-2029) Table 70. Eli Lilly and Company Corporation Information Table 71. Eli Lilly and Company Description and Business Overview Table 72. Eli Lilly and Company Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. Eli Lilly and Company Recombinant Hormone Product Table 74. Eli Lilly and Company Recent Developments/Updates Table 75. Ferring Pharmaceuticals Corporation Information Table 76. Ferring Pharmaceuticals Description and Business Overview Table 77. Ferring Pharmaceuticals Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. Ferring Pharmaceuticals Recombinant Hormone Product Table 79. Ferring Pharmaceuticals Recent Developments/Updates Table 80. Merck Corporation Information Table 81. Merck Description and Business Overview Table 82. Merck Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Merck Recombinant Hormone Product Table 84. Merck Recent Developments/Updates Table 85. Pfizer Corporation Information Table 86. Pfizer Description and Business Overview Table 87. Pfizer Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Pfizer Recombinant Hormone Product Table 89. Pfizer Recent Developments/Updates Table 90. Novo Nordisk Corporation Information Table 91. Novo Nordisk Description and Business Overview Table 92. Novo Nordisk Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Novo Nordisk Recombinant Hormone Product Table 94. Novo Nordisk Recent Developments/Updates Table 95. Novartis AG Corporation Information Table 96. Novartis AG Description and Business Overview Table 97. Novartis AG Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Novartis AG Recombinant Hormone Product Table 99. Novartis AG Recent Developments/Updates Table 100. Ipsen Corporation Information Table 101. Ipsen Description and Business Overview Table 102. Ipsen Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Ipsen Recombinant Hormone Product Table 104. Ipsen Recent Developments/Updates Table 105. LG Chem Corporation Information Table 106. LG Chem Description and Business Overview Table 107. LG Chem Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. LG Chem Recombinant Hormone Product Table 109. LG Chem Recent Developments/Updates Table 110. Teva Pharmaceutical Corporation Information Table 111. Teva Pharmaceutical Description and Business Overview Table 112. Teva Pharmaceutical Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Teva Pharmaceutical Recombinant Hormone Product Table 114. Teva Pharmaceutical Recent Developments/Updates Table 115. Scripps Laboratories Corporation Information Table 116. Scripps Laboratories Description and Business Overview Table 117. Scripps Laboratories Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Scripps Laboratories Recombinant Hormone Product Table 119. Scripps Laboratories Recent Developments/Updates Table 120. Key Raw Materials Lists Table 121. Raw Materials Key Suppliers Lists Table 122. Recombinant Hormone Distributors List Table 123. Recombinant Hormone Customers List Table 124. Recombinant Hormone Market Trends Table 125. Recombinant Hormone Market Drivers Table 126. Recombinant Hormone Market Challenges Table 127. Recombinant Hormone Market Restraints Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Recombinant Hormone Figure 2. Global Recombinant Hormone Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Recombinant Hormone Market Share by Type in 2022 & 2029 Figure 4. Growth Hormone Product Picture Figure 5. Insulin Product Picture Figure 6. Follicle-stimulating Hormone Product Picture Figure 7. Others Product Picture Figure 8. Global Recombinant Hormone Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 9. Global Recombinant Hormone Market Share by Application in 2022 & 2029 Figure 10. Hospital Figure 11. Clinic Figure 12. Others Figure 13. Global Recombinant Hormone Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 14. Global Recombinant Hormone Market Size (2018-2029) & (US$ Million) Figure 15. Global Recombinant Hormone Sales (2018-2029) & (K Units) Figure 16. Global Recombinant Hormone Average Price (US$/Unit) & (2018-2029) Figure 17. Recombinant Hormone Report Years Considered Figure 18. Recombinant Hormone Sales Share by Manufacturers in 2022 Figure 19. Global Recombinant Hormone Revenue Share by Manufacturers in 2022 Figure 20. The Global 5 and 10 Largest Recombinant Hormone Players: Market Share by Revenue in 2022 Figure 21. Recombinant Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 22. Global Recombinant Hormone Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 23. North America Recombinant Hormone Sales Market Share by Country (2018-2029) Figure 24. North America Recombinant Hormone Revenue Market Share by Country (2018-2029) Figure 25. United States Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 26. Canada Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. Europe Recombinant Hormone Sales Market Share by Country (2018-2029) Figure 28. Europe Recombinant Hormone Revenue Market Share by Country (2018-2029) Figure 29. Germany Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. France Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. U.K. Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Italy Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. Russia Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Asia Pacific Recombinant Hormone Sales Market Share by Region (2018-2029) Figure 35. Asia Pacific Recombinant Hormone Revenue Market Share by Region (2018-2029) Figure 36. China Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. Japan Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. South Korea Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. India Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Australia Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. China Taiwan Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Indonesia Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Thailand Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Malaysia Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Latin America Recombinant Hormone Sales Market Share by Country (2018-2029) Figure 46. Latin America Recombinant Hormone Revenue Market Share by Country (2018-2029) Figure 47. Mexico Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Brazil Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Argentina Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Recombinant Hormone Sales Market Share by Country (2018-2029) Figure 51. Middle East & Africa Recombinant Hormone Revenue Market Share by Country (2018-2029) Figure 52. Turkey Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. Saudi Arabia Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. UAE Recombinant Hormone Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. Global Sales Market Share of Recombinant Hormone by Type (2018-2029) Figure 56. Global Revenue Market Share of Recombinant Hormone by Type (2018-2029) Figure 57. Global Recombinant Hormone Price (US$/Unit) by Type (2018-2029) Figure 58. Global Sales Market Share of Recombinant Hormone by Application (2018-2029) Figure 59. Global Revenue Market Share of Recombinant Hormone by Application (2018-2029) Figure 60. Global Recombinant Hormone Price (US$/Unit) by Application (2018-2029) Figure 61. Recombinant Hormone Value Chain Figure 62. Recombinant Hormone Production Process Figure 63. Channels of Distribution (Direct Vs Distribution) Figure 64. Distributors Profiles Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Eli Lilly and Company Ferring Pharmaceuticals Merck Pfizer Novo Nordisk Novartis AG Ipsen LG Chem Teva Pharmaceutical Scripps Laboratories